http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101789475-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0662 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 |
filingDate | 2017-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101789475-B1 |
titleOfInvention | A composition for preventing or treating of osteoporosis comprising tonsil-derived mesenchymal stem cell or conditioned medium thereof |
abstract | The present invention relates to osteoporosis comprising mesenchyme-derived mesenchymal stem cells, a regulated medium thereof or all of them as an active ingredient, and a pharmaceutical composition for preventing or treating visceral obesity. The pharmaceutical composition of the present invention shows prominent preventive and therapeutic effects on osteoporosis and / or visceral obesity by promoting osteoblast differentiation, inhibiting adipocyte differentiation, reducing bone marrow fat, inhibiting visceral fat accumulation, and weight loss. |
priorityDate | 2017-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 349.